Navigation Links
Omeros Announces Submission to European Medicines Agency of Paediatric Investigation Plan Letter of Intent for OMS302
Date:11/29/2011

o add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.

Forward-looking Statements

This press release contains forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, which are subject to the "safe harbor" created by those sections. These statements include, but are not limited to, statements regarding the Company's expectations that data from the first Phase 3 trial of OMS302 will be available during the first quarter of 2012, that Omeros will initiate a second Phase 3 trial of OMS302 following discussions with regulators, that Omeros will be poised to file marketing applications as soon as possible following receipt of OMS302 Phase 3 clinical data , and that Omeros may have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Forward-looking statements are based on management's beliefs and assumptions and on information available to management only as of the date of this press release. Omeros' actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors described under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2011. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and the Company assumes no obligation to update these forward-looking statements publicly, even if new information becomes available in the future.


'/>"/>
SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
2. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
3. Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
4. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
5. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
6. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
7. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
8. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
9. Daniel K. Spiegelman Elected to Board of Directors of Omeros
10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
11. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014 Since last ... the site now known as the leading online black ... seen explosive growth in its offering of drugs and ... Alliance show the takedowns did succeed in lowering the ... last review of the markets in August. But some ...
(Date:12/17/2014)... Los beneficios y ganancias están ... de gasto en investigación y desarrollo   ... de septiembre de 2014) ZEISS aumentó sus ingresos en ... (año anterior: 4.190 millones de euros) a pesar de ... crecieron un 14 por ciento, a 360 millones de ...
(Date:12/17/2014)... 2014  Beamz Interactive, Inc. (OTCQB: BZIC), a ... announced that it has signed an agreement with ... of innovative prosthetic, orthotic and assistive technology products ... agreement, RSL Steeper will promote and supply the ... use within UK residential care facilities through its ...
Breaking Medicine Technology:Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3ZEISS confirma su posición en un entorno difícil 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3
... CORAL GABLES, Fla., Oct. 1 Catalyst Pharmaceutical Partners, Inc. ... entered into definitive agreements to sell 3.97 million shares of ... pursuant to a registered direct offering to several select institutional ... closing of the offering is expected to take place on ...
... This fall, dog owners in New York City will ... in the park. Veterinarians on the Mobile Dog Heart Health ... a soundproof medical unit to perform free heart examinations for ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20091001/CG85941 ) , In addition to performing ...
Cached Medicine Technology:Catalyst Pharmaceutical Partners, Inc. To Raise $3.97 Million In Registered Direct Offering 2Catalyst Pharmaceutical Partners, Inc. To Raise $3.97 Million In Registered Direct Offering 3Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations 2Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations 3
(Date:12/21/2014)... AlignLife of Norton Shores is spreading ... same time helping people get their health back. Mission ... to serving those persons in Muskegon County who are unable ... quality of life. Dr. Michael Rykse wanted to do a ... community and he knew he found that when he heard ...
(Date:12/21/2014)... December 21, 2014 Theme ... a new intro plugin for Final Cut Pro X ... videos, logos, and more with absolute ease.” Said Christiana ... users the tools needed to easily animate their media ... Cut Pro X users to animate pictures, videos, logos, ...
(Date:12/20/2014)... 21, 2014 BambooIndustry.com is a professional ... . The business has recently shown its new engineered ... all its bamboo flooring models. , BambooIndustry.com’s customers come ... Asia and more. According to the CEO of the ... very fast in the past few years, and the ...
(Date:12/20/2014)... Dress company LunaDress has recently announced its 2015 collection ... big discounts on all of its special occasion dresses & ... a perfect wedding gown. If you have no idea of ... LunaDress. Many different wedding dress styles and our dress experts ... enjoy the current special offer, up to 80% off," the ...
(Date:12/20/2014)... 20, 2014 The Doctor’s Office Urgent Care ... better part of a decade. They’ve treated over 40,000 ... faster healthcare alternative to the Paramus area. ... new additions to their staff of top-notch board certified physicians: ... MD. These new doctors will work tirelessly to ...
Breaking Medicine News(10 mins):Health News:AlignLife of Norton Shores Makes a Brighter Christmas for Kids in Muskegon 2Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2
... Low-Power Design for Innovative Medical ... ... SNPS ), a world leader in software and IP for semiconductor design,and ... signal processor (DSP) chipset for hearing-aid,devices using Synopsys, IC Compiler design planning ...
... football players, but they aren,t necessarily dangerous, experts say ... players are twice as likely as whites to have ... that doesn,t mean they are at greater risk of ... 2,000 athletes, done at the National Football League Invitational ...
... TOWSON, Md., June 2 Katzen Eye Group ... Refractive Therapy, Paragon CRT.,Paragon CRT temporarily corrects nearsightedness ... dedication to the health of their patients, Katzen ... the latest,advancements in vision care. Paragon CRT is ...
... and Grammy Award-Winning Music,Icons in Cancer Awareness Campaign, ... an estimated 260,000 women will be diagnosed with breast, ... 69,000,women will die from these diseases. In response, a ... to communicate a very,important message to all American women: ...
... early psychotic symptoms, researchers say , , MONDAY, June 2 ... long time can develop abnormalities in their brains, Australian ... marijuana use is associated with a wide range of ... harmless and should be legalized, the researchers noted. , ...
... UT Southwestern Medical Center physician and other researchers have ... of a patient being cancer free 12 years after ... a nomogram, uses tumor and patient characteristics to maximize ... the cancer,s return can help clinicians counsel patients and ...
Cached Medicine News:Health News:Oticon Tapes Out Innovative Hearing-Aid DSP Using Synopsys IC Compiler 2Health News:Oticon Tapes Out Innovative Hearing-Aid DSP Using Synopsys IC Compiler 3Health News:Black Athletes' Hearts May Differ From Those of Whites 2Health News:Black Athletes' Hearts May Differ From Those of Whites 3Health News:Katzen Eye Group Announces a New Option in Vision Correction Technology for Patients 2Health News:Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 2Health News:Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 3Health News:Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 4Health News:Marijuana May Shrink Parts of the Brain 2Health News:Marijuana May Shrink Parts of the Brain 3Health News:New model predicts whether patients will be free of renal cancer 12 years after initial treatment 2